This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glenn, G. M.
Right arrow Articles by Alving, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glenn, G. M.
Right arrow Articles by Alving, C. R.

 Previous Article  |  Next Article 

Infection and Immunity, March 1999, p. 1100-1106, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins as Antigens and Adjuvants

Gregory M. Glenn,1,2,* Tanya Scharton-Kersten,1,2 Russell Vassell,1,2 Gary R. Matyas,1 and Carl R. Alving1

Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100,1 and IOMAI Corp., Washington, D.C. 200372

Received 1 September 1998/Returned for modification 14 October 1998/Accepted 30 November 1998

Transcutaneous immunization (TCI) is a new technique that uses the application of vaccine antigens in a solution on the skin to induce potent antibody responses without systemic or local toxicity. We have previously shown that cholera toxin (CT), a potent adjuvant for oral and nasal immunization, can induce both serum and mucosal immunoglobulin G (IgG) and IgA and protect against toxin-mediated mucosal disease when administered by the transcutaneous route. Additionally, CT acts as an adjuvant for coadministered antigens such as tetanus and diphtheria toxoids when applied to the skin. CT, a member of the bacterial ADP-ribosylating exotoxin (bARE) family, is most potent as an adjuvant when the A-B subunits are present and functional. We now show that TCI induces secondary antibody responses to coadministered antigens as well as to CT in response to boosting immunizations. IgG antibodies to coadministered antigens were also found in the stools and lung washes of immunized mice, suggesting that TCI may target mucosal pathogens. Mice immunized by the transcutaneous route with tetanus fragment C and CT developed anti-tetanus toxoid antibodies and were protected against systemic tetanus toxin challenge. We also show that bAREs, similarly organized as A-B subunits, as well as the B subunit of CT alone, induced antibody responses to themselves when given via TCI. Thus, TCI appears to induce potent, protective immune responses to both systemic and mucosal challenge and offers significant potential practical advantages for vaccine delivery.


* Corresponding author. Mailing address: Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Bldg. 40, Rm. 3049, 14th and Dahlia Sts. NW, Washington, DC 20307-5100. Phone: (202) 782-3137. Fax: (202) 782-1890. E-mail: gglenn{at}iomai.com.


Infection and Immunity, March 1999, p. 1100-1106, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zhu, C., Yu, J., Yang, Z., Davis, K., Rios, H., Wang, B., Glenn, G., Boedeker, E. C. (2008). Protection against Shiga Toxin-Producing Escherichia coli Infection by Transcutaneous Immunization with Shiga Toxin Subunit B. CVI 15: 359-366 [Abstract] [Full Text]  
  • Ghose, C., Kalsy, A., Sheikh, A., Rollenhagen, J., John, M., Young, J., Rollins, S. M., Qadri, F., Calderwood, S. B., Kelly, C. P., Ryan, E. T. (2007). Transcutaneous Immunization with Clostridium difficile Toxoid A Induces Systemic and Mucosal Immune Responses and Toxin A-Neutralizing Antibodies in Mice. Infect. Immun. 75: 2826-2832 [Abstract] [Full Text]  
  • Rollenhagen, J. E., Kalsy, A., Cerda, F., John, M., Harris, J. B., LaRocque, R. C., Qadri, F., Calderwood, S. B., Taylor, R. K., Ryan, E. T. (2006). Transcutaneous Immunization with Toxin-Coregulated Pilin A Induces Protective Immunity against Vibrio cholerae O1 El Tor Challenge in Mice.. Infect. Immun. 74: 5834-5839 [Abstract] [Full Text]  
  • Zhang, J., Shi, Z., Kong, F.-k., Jex, E., Huang, Z., Watt, J. M., Van Kampen, K. R., Tang, D.-c. C. (2006). Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity.. Infect. Immun. 74: 3607-3617 [Abstract] [Full Text]  
  • Guebre-Xabier, M., Hammond, S. A., Ellingsworth, L. R., Glenn, G. M. (2004). Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice. J. Virol. 78: 7610-7618 [Abstract] [Full Text]  
  • Berry, L. J., Hickey, D. K., Skelding, K. A., Bao, S., Rendina, A. M., Hansbro, P. M., Gockel, C. M., Beagley, K. W. (2004). Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection. Infect. Immun. 72: 1019-1028 [Abstract] [Full Text]  
  • Riminton, D. S., Kandasamy, R., Dravec, D., Basten, A., Baxter, A. G. (2004). Dermal Enhancement: Bacterial Products on Intact Skin Induce and Augment Organ-Specific Autoimmune Disease. J. Immunol. 172: 302-309 [Abstract] [Full Text]  
  • Anjuere, F., George-Chandy, A., Audant, F., Rousseau, D., Holmgren, J., Czerkinsky, C. (2003). Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses. J. Immunol. 170: 1586-1592 [Abstract] [Full Text]  
  • Beignon, A.-S., Briand, J.-P., Rappuoli, R., Muller, S., Partidos, C. D. (2002). The LTR72 Mutant of Heat-Labile Enterotoxin of Escherichia coli Enhances the Ability of Peptide Antigens To Elicit CD4+ T Cells and Secrete Gamma Interferon after Coapplication onto Bare Skin. Infect. Immun. 70: 3012-3019 [Abstract] [Full Text]  
  • Poland, G. A, Murray, D., Bonilla-Guerrero, R. (2002). Science, medicine, and the future: New vaccine development. BMJ 324: 1315-1319 [Full Text]  
  • Guerena-Burgueno, F., Hall, E. R., Taylor, D. N., Cassels, F. J., Scott, D. A., Wolf, M. K., Roberts, Z. J., Nesterova, G. V., Alving, C. R., Glenn, G. M. (2002). Safety and Immunogenicity of a Prototype Enterotoxigenic Escherichia coli Vaccine Administered Transcutaneously. Infect. Immun. 70: 1874-1880 [Abstract] [Full Text]  
  • Arrington, J., Braun, R. P., Dong, L., Fuller, D. H., Macklin, M. D., Umlauf, S. W., Wagner, S. J., Wu, M. S., Payne, L. G., Haynes, J. R. (2002). Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coli Are Strong Adjuvants for DNA Vaccines. J. Virol. 76: 4536-4546 [Abstract] [Full Text]  
  • Yu, J., Cassels, F., Scharton-Kersten, T., Hammond, S. A., Hartman, A., Angov, E., Corthesy, B., Alving, C., Glenn, G. (2002). Transcutaneous Immunization Using Colonization Factor and Heat-Labile Enterotoxin Induces Correlates of Protective Immunity for Enterotoxigenic Escherichia coli. Infect. Immun. 70: 1056-1068 [Abstract] [Full Text]  
  • Shi, Z., Zeng, M., Yang, G., Siegel, F., Cain, L. J., van Kampen, K. R., Elmets, C. A., Tang, D.-C. C. (2001). Protection against Tetanus by Needle-Free Inoculation of Adenovirus-Vectored Nasal and Epicutaneous Vaccines. J. Virol. 75: 11474-11482 [Abstract] [Full Text]  
  • Chen, D., Periwal, S. B., Larrivee, K., Zuleger, C., Erickson, C. A., Endres, R. L., Payne, L. G. (2001). Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization. J. Virol. 75: 7956-7965 [Abstract] [Full Text]  
  • Scharton-Kersten, T., Yu, J.-m., Vassell, R., O'Hagan, D., Alving, C. R., Glenn, G. M. (2000). Transcutaneous Immunization with Bacterial ADP-Ribosylating Exotoxins, Subunits, and Unrelated Adjuvants. Infect. Immun. 68: 5306-5313 [Abstract] [Full Text]  
  • Weltzin, R., Guy, B., Thomas, W. D. Jr., Giannasca, P. J., Monath, T. P. (2000). Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection. Infect. Immun. 68: 2775-2782 [Abstract] [Full Text]